U.S. markets closed

Zymergen Inc. (ZY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2700-0.0500 (-3.79%)
At close: 04:00PM EDT
1.3000 +0.03 (+2.36%)
After hours: 07:41PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.3200
Bid1.2600 x 900
Ask1.3100 x 1200
Day's Range1.2000 - 1.3600
52 Week Range1.2000 - 46.0500
Avg. Volume1,148,685
Market Cap130.989M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.6100
Earnings DateMay 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ZY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zymergen Inc.
    Daily – Vickers Top Buyers & Sellers for 11/22/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more
  • Motley Fool

    Zymergen Inc. (ZY) Q1 2022 Earnings Call Transcript

    If you require any further assistance, I would now like to hand the conference over to your host today, Carrie Mendivil from investor relations. Earlier today, Zymergen released preliminary substantial results for the quarter ended March 31, 2022. Joining me today from Zymergen are Jay Flatley, acting chief executive officer, and Ena Singh, chief financial officer.

  • Zacks

    Zymergen (ZY) Reports Q1 Loss, Tops Revenue Estimates

    Zymergen (ZY) delivered earnings and revenue surprises of 1.41% and 57.08%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Zymergen Reports Preliminary First Quarter 2022 Financial Results

    EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the first quarter ended March 31, 2022. “Our mission at Zymergen is to partner with nature to make better products, a better way, for a better world. One of the key transformations we have made is to create a nimble, disciplined product development process,” said Zymergen’s interim CEO, Jay Flatley. “We now have the infrastructur